ADPT Adaptive Biotechnologies Corp: Multiplikator Forward P/S
Adaptive Biotechnologies relies on high-precision automated immune mapping laboratories, as confirmed by the projected P/S metric on the current GURU.Markets platform chart, where the current figure is 16.00. The company strives for leadership in T-cell receptor sequencing to develop targeted therapies. Monitoring systems for minimal residual disease in oncology ensure stable growth, despite significant investments in research and development.
Rincian metrik keuangan lan pasar Adaptive Biotechnologies Inc. (ADPT)
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
- statistik nilai buku emiten:
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Adaptive Biotechnologies|ADPT - Kewajiban jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Adaptive Biotechnologies|ADPT - Tanggungan utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Adaptive Biotechnologies Inc.|ADPT - Gunggunge utang jangka dawa|Kewajiban jangka cendhak perusahaan Adaptive Biotechnologies|Rasio cepet adaptivebiotech.com
- rincian asil keuangan lan kelipatan valuasi:
ADPT - Penghasilan resik perusahaan|Bathi mangsa ngarep Adaptive Biotechnologies|ADPT - Nilai perusahaan marang bathi resik|Pangali Forward P/E Adaptive Biotechnologies Corp|ADPT - Rasio rega marang bathi tumrap wutah|Pangali EV/EBITDA Adaptive Biotechnologies Inc.|ADPT - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Adaptive Biotechnologies|ADPT - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan adaptivebiotech.com|ADPT - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Adaptive Biotechnologies
- indikator dodolan lan pendapatan:
Analisis umum perusahaan:Adaptive Biotechnologies Corporation ADPT
The complexity of AI-driven immune mapping and patent protection drive the high business valuation of Adaptive Biotechnologies (ADPT). By analyzing the issuer's forward P/S ratio, investors compare market capitalization against expected revenue, which allows them to determine the premium paid for technological leadership or identify hidden valuation vulnerabilities amid stringent FDA regulation and reliance on biomedical grants.
Analisis perusahaan pesaing
Multiplikator Forward P/S ARGX (argenx)|BioNTech Inc. (BNTX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Abivax Corp - Multiplikator Forward P/S|ADMA - Multiplikator Forward P/S|PTGX: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan IMVT|KNSA (Kiniksa) - Multiplikator Forward P/S|Multiplikator Forward P/S Grifols SA|Rasio rega marang prakiraan pendapatan Celldex (CLDX)|AUPH: Rega mangsa ngarep marang pendapatan|BioCryst - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake VERA (veratx.com)|Dianthus Therapeutics, Inc. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Pharvaris NV PHVS|ABCL (AbCellera Biologics Inc) - Multiplikator forward rega marang pendapatan|TRML (Tourmaline) - Rasio rega marang prakiraan pendapatan|PGEN (Precigen, Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep pharming.com PHAR|Multiplikator forward rega marang pendapatan NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio, Inc.) - Rega forward marang dodolan|Multiplikator Forward P/S ZBIO (Zenas Biopharma, Inc.)|Immunome Bio - Rasio rega marang prakiraan pendapatan|Gossamer Bio, Inc. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake kalvista.com KALV|Septerna (SEPN) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Pieris Pharma (PVLA)|Multiplikator forward rega marang pendapatan SVRA|RIGL (Rigel Corp) - Rasio rega marang pendapatan sing dikarepake|Multiplikator Forward P/S ANAB|ATXS - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S ENGN (enGene)|RAPT - Multiplikator forward rega marang pendapatan|Aerovate - Multiplikator Forward P/S|Rega forward marang dodolan ACRS (Aclaris Therapeutics, Inc)|Kyverna Therapeutics (KYTX) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan TLSA|Rasio rega marang prakiraan pendapatan Cabaletta Bio|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Ventyx Biosciences Inc. VTYX|Rasio rega marang prakiraan pendapatan Theratechnologies Inc (THTX)|Rasio rega marang prakiraan pendapatan AVTX (Avalo Therapeutics Inc)|Rasio rega marang prakiraan pendapatan Eledon Pharmaceuticals ELDN|agenusbio.com (AGEN) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Climb Bio - Multiplikator Forward P/S|Prakiraan rega marang pendapatan Zura Bio Ltd (ZURA)|ATYR: Multiplikator Forward P/S|ADAG - Rasio kapitalisasi marang dodolan sing dikarepake|IMA (ImageneBio) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Shattuck Therapeutics STTK|Rasio rega marang prakiraan pendapatan Equillium, Inc. (EQ)|Rasio kapitalisasi marang dodolan sing dikarepake connectbiopharm.com|Multiplikator Forward P/S IMUX (Immunic)|Multiplikator Forward P/S Atara Biotherapeutics, Inc. ATRA|InflaRx GmbH - Multiplikator Forward P/S|XFOR (x4pharma.com) - Kapitalisasi marang prakiraan pendapatan|adicetbio.com (ACET) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CELU (Celularity)|Multiplikator forward rega marang pendapatan INMB|BRNS (Barinthus Biotherapeutics Corp) - Rasio rega marang pendapatan sing dikarepake|Rasio rega marang prakiraan pendapatan Kezar Life Sciences (KZR)|SABS: Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S AKTX (Akari Therapeutics Plc)|Rega forward marang dodolan ENLV|Q32 Bio Corp - Multiplikator Forward P/S|GOVX - Multiplikator Forward P/S|Edesa Biotech, Inc. (EDSA) - Rasio rega marang prakiraan pendapatan|ibioinc.com - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Carisma Therapeutics Inc|Multiplikator forward rega marang pendapatan XTL Biopharmaceuticals Ltd (XTLB)|Multiplikator Forward P/S BOLT|Multiplikator Forward P/S hcwbiologics.com (HCWB)|Aptevo Therapeutics Inc. - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan AIM|Aditxt Corp - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake GRI Bio Inc GRI|XORTX (XRTX) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Vyome Therapeutics|Rasio rega marang prakiraan pendapatan Revelation Biosciences|Multiplikator forward rega marang pendapatan indaptusrx.com (INDP)|Multiplikator forward rega marang pendapatan SCNI (Scinai Immunotherapeutics Ltd.)|Multiplikator Forward P/S calcimedica.com (CALI)|Rasio rega marang prakiraan pendapatan Affimed N.V. AFMD|ALLK: Kapitalisasi marang prakiraan pendapatan|HOOKIPA - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep IGM Biosciences, Inc.|ITOS: Multiplikator Forward P/S|Ocean Biomedical Inc (OCEA) - Multiplikator Forward P/S|TCBP (TC BioPharm (Holdings) PLC) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan THRD (Third Harmonic Bio Inc)
